2013

1. Phase ii study of irinotecan in combination with capecitabine on a 3-weekly schedule as first-line chemotherapy for patients with metastatic or locally advanced colorectal cancer

   Journal of Analytical Oncology, Vol. 2, Núm. 3, pp. 151-159